Title: Evans DM, et al. Exposure time versus cytotoxicity for anticancer agents.Cancer Chemother Pharmacol. 2019 Aug;84(2):359-371.
Title: Jung M, et al. Targeting BET bromodomains for cancer treatment. Epigenomics. 2015;7(3):487-501.
1808011-22-4 | EPZ031686 | AA00ABOP | MFCD30181978
172602-83-4 | Ethyl 1-cyclopropyl-8-ethoxy-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate | AA00ABWI | MFCD30186988
153724-93-7 | E-2-Chloromethylvinylboronic acid pinacol ester | AA00AC9U | MFCD09260446
19460-85-6 | Bzl-Ala-OMe HCl | AA00ACO9 | MFCD02684375
149489-17-8 | 2-(3-Isopropoxyphenyl)ethanamine | AA00ACUN | MFCD05670648
180790-90-3 | 2-(Methylthio)isonicotinonitrile | AA00AD1F | MFCD12198460
172455-36-6 | 4-Amino-2-chloro-5-nitro-benzonitrile | AA00AD88 | MFCD26401904
147852-26-4 | (R)-(-)-Repaglinide (Repaglinide Impurity) | AA00ADEI | MFCD16294178
17680-99-8 | (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(p-tolyloxy)tetrahydro-2H-pyran-2-carboxylic acid | AA00ADN3 | MFCD08277028
16281-43-9 | 1-Oxo-3-methyl-8-hydroxy-3,4-dihydro-1H-2-benzopyran-7-carboxylic acid | AA00ADV4